SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Exozymes Inc. (NASDAQ:EXOZ)

US · Delayed Price · Currency is USD
6.02+0.48 (+8.66%)
 
Market Cap55.87M-55.6%
Revenue (ttm)0
Net Income-10.19M-32.2%
EPS-1.20-4.3%
Shares Out9.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,009.637
Open5.69
Previous Close5.54
Day's Range5.38 - 6.34
52-Week Range4.35 - 18.40
Beta3.19
Analystsn/a
Price Targetn/a
Earnings DateNov 12, 2026
+8.66% (1D)
No price history available.
Insider Score
/ 100
EXOZ Insider Score

EXOZYMES INC. has a live Insider Score.

Scored on 5 qualifying trades from 1 insider in the last 90 days.

Unlock the score

About EXOZ

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Address
750 Royal Oaks Drive, Monrovia, CA, 91016, US
Market Cap
56 million
Employees
32
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$15.43K
Bought
$6.41K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+4.69%
5 Days
-1.19%
1 Month
-8.08%
6 Months
-44.50%
1 Year
-55.62%

$EXOZ stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in EXOZ holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by EXOZ's directors and management

Net Shares Purchased by Insiders−2k−1k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

EXOZ Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New EXOZ patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to EXOZ from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in EXOZ

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$623.74K
VXFVanguard Extended Market ETF$161.31K
IWCiShares Micro-Cap ETF$60.01K

Estimated from each fund’s disclosed top holdings × AUM

EXOZ Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for EXOZ is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from EXOZ’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
5
Sells
2
Buy Value
$6.41K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Exozymes Inc. (EXOZ) Insider Trading, Form 4 Buys & Sells | InsiderBuying.com